BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17157014)

  • 1. Inhibitors of the FEZ-1 metallo-beta-lactamase.
    Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.
    Lassaux P; Hamel M; Gulea M; Delbrück H; Mercuri PS; Horsfall L; Dehareng D; Kupper M; Frère JM; Hoffmann K; Galleni M; Bebrone C
    J Med Chem; 2010 Jul; 53(13):4862-76. PubMed ID: 20527888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
    Liénard BM; Garau G; Horsfall L; Karsisiotis AI; Damblon C; Lassaux P; Papamicael C; Roberts GC; Galleni M; Dideberg O; Frère JM; Schofield CJ
    Org Biomol Chem; 2008 Jul; 6(13):2282-94. PubMed ID: 18563261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
    Kurosaki H; Yamaguchi Y; Higashi T; Soga K; Matsueda S; Yumoto H; Misumi S; Yamagata Y; Arakawa Y; Goto M
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3861-4. PubMed ID: 15892033
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of serine amidohydrolases by complexes of vanadate with hydroxamic acids.
    Bell JH; Curley K; Pratt RF
    Biochem Biophys Res Commun; 2000 Aug; 274(3):732-5. PubMed ID: 10924345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing, inhibition, and crystallographic characterization of metallo-beta-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups.
    Kurosaki H; Yamaguchi Y; Yasuzawa H; Jin W; Yamagata Y; Arakawa Y
    ChemMedChem; 2006 Sep; 1(9):969-72. PubMed ID: 16937423
    [No Abstract]   [Full Text] [Related]  

  • 8. New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design.
    Olsen L; Jost S; Adolph HW; Pettersson I; Hemmingsen L; Jørgensen FS
    Bioorg Med Chem; 2006 Apr; 14(8):2627-35. PubMed ID: 16378729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyl groups in the betabeta sandwich of metallo-beta-lactamases favor enzyme activity: Tyr218 and Ser262 pull down the lid.
    Oelschlaeger P; Pleiss J
    J Mol Biol; 2007 Feb; 366(1):316-29. PubMed ID: 17157873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors.
    Liénard BM; Hüting R; Lassaux P; Galleni M; Frère JM; Schofield CJ
    J Med Chem; 2008 Feb; 51(3):684-8. PubMed ID: 18205296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
    Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A
    Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site.
    Wyrembak PN; Babaoglu K; Pelto RB; Shoichet BK; Pratt RF
    J Am Chem Soc; 2007 Aug; 129(31):9548-9. PubMed ID: 17628063
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of Bacillus anthracis metallo-β-lactamase by compounds with hydroxamic acid functionality.
    Kim SK; Demuth M; Schlesinger SR; Kim SJ; Urbanczyk J; Shaw RW; Shin H
    J Enzyme Inhib Med Chem; 2016; 31(sup4):132-137. PubMed ID: 27557855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal content and localization during turnover in B. cereus metallo-beta-lactamase.
    Llarrull LI; Tioni MF; Vila AJ
    J Am Chem Soc; 2008 Nov; 130(47):15842-51. PubMed ID: 18980306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
    Badarau A; Llinás A; Laws AP; Damblon C; Page MI
    Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of beta-lactamase.
    Buynak JD; Ghadachanda VR; Vogeti L; Zhang H; Chen H
    J Org Chem; 2005 May; 70(11):4510-3. PubMed ID: 15903334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to the inhibition of metallo-beta-lactamases.
    Spencer J; Walsh TR
    Angew Chem Int Ed Engl; 2006 Feb; 45(7):1022-6. PubMed ID: 16404761
    [No Abstract]   [Full Text] [Related]  

  • 18. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
    Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
    Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of peroxidase-catalyzed iodination by cephalosporins: Metallo-beta-lactamase-induced antithyroid activity of antibiotics.
    Tamilselvi A; Mugesh G
    ChemMedChem; 2009 Apr; 4(4):512-6. PubMed ID: 19107757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily.
    Bebrone C
    Biochem Pharmacol; 2007 Dec; 74(12):1686-701. PubMed ID: 17597585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.